| Kami Black, | |
|
141 W Gailey Ln, Kaysville, UT 84037-1937 | |
| (801) 867-4292 | |
| Not Available |
| Full Name | Kami Black |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 141 W Gailey Ln, Kaysville, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992136550 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 5061350-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kami Black, 141 W Gailey Ln, Kaysville, UT 84037-1937 Ph: () - | Kami Black, 141 W Gailey Ln, Kaysville, UT 84037-1937 Ph: (801) 867-4292 |
News Archive
Sophia Genetics, global leader in Data-Driven Medicine, unveiled today a new privacy-protecting technology for the storage and access to patients' genomic information worldwide, paving the way to a new industry standard.
Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.
You win some, you lose some. A protein that protects the body from tissue damage also increases the risk of tumors, according to a study conducted at Washington University School of Medicine in St. Louis. Moderate reduction of the protein level protects against tumor formation but increases susceptibility to tissue injury.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
› Verified 3 days ago
Wendi Christensen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 420 Houston Ct, Kaysville, UT 84037 Phone: 801-369-5029 | |
Mr. Bernard George Vetter, MSW DCSW BCD LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 206 E Monticello Dr, Kaysville, UT 84037 Phone: 801-309-1079 | |
Matthew Loveland, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 31 W Center St, Kaysville, UT 84037 Phone: 801-660-5557 | |
Mrs. Rachael Anne Jasperson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 375 N Main St Ste 202, Kaysville, UT 84037 Phone: 818-642-9397 | |
Shawna Flinders, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 275 W 200 N Ste 7, Kaysville, UT 84037 Phone: 801-546-1300 | |
Jaclyn Randolph, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 375 N Main St, Kaysville, UT 84037 Phone: 801-844-1615 | |
Adam Ross Mackay, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 447 N 300 W Ste 7, Kaysville, UT 84037 Phone: 801-414-5894 Fax: 801-451-5073 |